Treating preterm infants at risk for chronic lung disease with dexamethasone leads to an impaired quality of general movements

Biology of the Neonate

Volumn 82, Issue 3, 2002, Pages 155-158

  Bos, Arend F ^a   Dibiasi, Jasmin ^b   Tiessen, Ansje H ^a   Bergman, Klasien A ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Corticosteroids; Development; General movements; Infant; Preterm

Indexed keywords

DEXAMETHASONE;

ARTICLE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GROWTH INHIBITION; HUMAN; INFANT; MOVEMENT (PHYSIOLOGY); POSTNATAL CARE; PREMATURITY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REDUCTION;

CHRONIC DISEASE; DEXAMETHASONE; ECHOENCEPHALOGRAPHY; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG DISEASES; MOVEMENT DISORDERS; RISK FACTORS;

EID: 0036427067     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063612     Document Type: Article

References (14)

1. Doyle LW, Davis PG: Postnatal corticosteroids in preterm infants: Systematic review of effects on mortality and motor function. J Paediatr Child Health 2000;36:101-107.
2. Halliday HL: Clinical trials of postnatal corticosteroids: Inhaled and systemic. Biol Neonate 1999;76(suppl 1):29-40.
3. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, Yurman S, Dolfin T, Kogan A, Dollberg S, Arbel E, Goldberg M, Gur I, Naor N, Sirota L, Mogilner S, Zaritsky A, Barak M, Gottfried E: Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child 2000;83: F177-F181.
4. Cummings JJ, D'Eugenio DB, Gross SJ: A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 1989;320:1505-1510.
5. O'Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson BG, Weaver RG, Dillard RG: Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age. Pediatrics 1999;104:15-21.
6. Bos AF, Martijn A, van Asperen RM, Hadders-Algra M, Okken A, Prechtl HFR: Qualitative assessment of general movements in high risk preterm infants with chronic lung disease requiring dexamethasone therapy. J Pediatr 1998;132:300-306.
7. Prechtl HFR, Einspieler C, Cioni G, Bos AF, Ferrari F, Sontheimer D: An early marker for neurological deficits after perinatal brain lesions. Lancet 1997;349:1361-1363.
8. Papile L, Burstein J, Burstein R, Koffler H: Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-534.
9. de Vries LS, Eken P, Dubowitz LMS: The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res 1992;49:1-6.
10. Einspieler C, Prechtl HFR, Ferrari F, Cioni G, Bos AF: The qualitative assessment of general movements in preterm, term and young infants: Review of the methodology. Early Hum Dev 1997;50:47-60.
11. Ferrari F, Cioni G, Prechtl HFR: Qualitative changes of general movements in preterm infants with brain lesions. Early Hum Dev 1990; 23:193-231.
12. Bos AF, Martijn A, Okken A, Prechtl HFR: Quality of general movements in preterm infants with transient periventricular echodensities. Acta Paediatr 1998;87:328-335.
13. Tsubota S, Adachi N, Chen JF, Yorozuya T, Nagaro T, Arai T: Dexamethasone changes brain monoamine metabolism and aggravates ischemic neuronal damage in rats. Anesthesiology 1999;90:515-523.
14. Tuor UI, Simone CS, Barks JD, Post M: Dexamethasone prevents cerebral infarction without affecting cerebral blood flow in neonatal rats. Stroke 1993;24:452-457.